NCT03289338View on ClinicalTrials.gov

Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Charcot ArthropathyDiabetes Complications
Interventions
DRUG

Zoledronic Acid

Zoledronic acid 5mg intravenous once a month for 3 months

DRUG

Methylprednisolone

Methylprednisolone 1gm intravenous once a month for 3 months

DRUG

Placebos

Normal saline intravenous once a month for 3 months

Trial Locations (1)

160012

Department of Endocrinology, PGIMER, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03289338 - Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus | Biotech Hunter | Biotech Hunter